Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy

American Journal of Transplantation

Volumn 11, Issue 12, 2011, Pages 2635-2646

  Snanoudj, R ^a,b   Royal, V ^c   Elie, C ^a,b   Rabant, M ^b,c   Girardin, C ^a   Morelon, E ^a   Kreis, H ^a,b   Fournet, J C ^b,c   Noel L H ^b,c   Legendre, C ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Laboratoire d'Anatomopathologie   (France)

Author keywords

biopsy; Calcineurin inhibitors toxicity; histopathology; kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; ATROPHY; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GRAFT FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE DEGENERATION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY;

ADULT; ARTERIOLES; BIOLOGICAL MARKERS; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 82455199080     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03718.x     Document Type: Article

References (30)

1. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS,. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 2007; 7 (Pt 2): 1359-1375. (Pubitemid 46606940)
2. Calne RY, White DJ, Thiru S, et al,. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323-1327. (Pubitemid 9078430)
3. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M,. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699-705. (Pubitemid 14074555)
4. Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B,. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998; 49: 356-363. (Pubitemid 28271466)
5. Mihatsch MJ, Thiel G, Ryffel B,. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20 (Suppl 3): 759-771.
6. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333. (Pubitemid 37509740)
7. Meier-Kriesche HU, Schold JD, Kaplan B,. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289-1295. (Pubitemid 39013575)
8. Solez K, Colvin RB, Racusen LC, et al,. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760. (Pubitemid 351347767)
9. Solez K, Colvin RB, Racusen LC, et al,. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526. (Pubitemid 46376465)
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
11. Gray R., A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
12. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
13. R Development Core Team (2010). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available at
14. Sis B, Dadras F, Khoshjou F, Cockfield S, Mihatsch MJ, Solez K,. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006; 6: 1444-1450. (Pubitemid 44030328)
15. Myers BD, Sibley R, Newton L, et al,. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590-600. (Pubitemid 18073785)
16. Stegall MD, Park WD, Larson TS, et al,. The histology of solitary renal allografts at 1 and 5 Years after transplantation. Am J Transplant 2011; 11: 698-707.
17. Naesens M, Kuypers DR, Sarwal M,. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481-508.
18. Port FK, Bragg-Gresham JL, Metzger RA, et al,. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281-1286. (Pubitemid 35402598)
19. Furness PN, Taub N, Assmann KJ, et al,. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805-810. (Pubitemid 36617518)
20. Marcussen N, Olsen TS, Benediktsson H, Racusen L, Solez K,. Reproducibility of the Banff classification of renal allograft pathology. Inter- and intraobserver variation. Transplantation 1995; 60: 1083-1089.
21. Strom EH, Thiel G, Mihatsch MJ,. Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992. Transplant Proc 1994; 26: 2585-2587. (Pubitemid 24329240)
22. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD,. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004; 78: 557-565. (Pubitemid 39097102)
23. Naesens M, Lerut E, Damme BV, Vanrenterghem Y, Kuypers DR,. Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. Am J Transplant 2007; 7: 2114-2123. (Pubitemid 47247039)
24. Gourishankar S, Hunsicker LG, Jhangri GS, Cockfield SM, Halloran PF,. The stability of the glomerular filtration rate after renal transplantation is improving. J Am Soc Nephrol 2003; 14: 2387-2394. (Pubitemid 37052387)
25. Kandaswamy R, Humar A, Casingal V, Gillingham KJ, Ibrahim H, Matas AJ,. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Transplantation 2007; 83: 722-726. (Pubitemid 46569189)
26. Schena FP, Pascoe MD, Alberu J, et al,. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 2009; 87: 233-242.
27. Einecke G, Sis B, Reeve J, et al,. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
28. El-Zoghby ZM, Stegall MD, Lager DJ, et al,. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527-535.
29. Gourishankar S, Leduc R, Connett J, et al,. Pathological and clinical characterization of the 'troubled transplant': Data from the DeKAF study. Am J Transplant 2010; 10: 324-330.
30. Hidalgo LG, Campbell PM, Sis B, et al,. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microcirculation pathology and late graft failure. Am J Transplant 2009; 9: 2532-2541.